Training Report ON GENPACT Submitted to MAHARSHI MARKENDESHWAR UNIVERSITY‚ MULLANA In partial fulfillment of the requirement For the award of the degree of BACHELOR OF BUSINESS ADMINISTRATION (Industry Integrated) (IX trimester) Submitted by SUBHAJIT BISWAS Reg No: - 09-MBM-132 Roll No: - 1209438 Algol School of Management & Technology (2009-2012) Near Hero Honda Chowk‚ Sector - 34‚ Gurgaon‚ Haryana July 2012
Premium Management Business process outsourcing Business process
Contents Page 1. Introduction ........................................................................................................2 2. The stance of Pfizer ............................................................................................3 2.1 Theories of corporate social responsibility and ethics ...................................3 2.2 Pfizer ’s stance on CSR and ethics .........................................
Premium Business ethics Corporate social responsibility Social responsibility
Case Study of Genentech Inc. Company Background Genentech is considered as the founder of the bio-technology industry. It has been delivering on the promise of biotechnology for almost 30 years‚ using human genetic information to discover‚ develop‚ commercialize and manufacture bio-therapeutics that address significant unmet medical needs. It was founded by venture capitalist Robert A. Swanson and biochemist Dr. Herbert W. Boyer. Genentech is among the world’s leading biotech companies‚
Premium Genentech Pharmaceutical industry Cancer
CASE STUDY a case of an ugly duckling By Prakash Waknis A case of an introvert‚ but‚ highly talented employee who has to deal with colleagues who are ’man-eaters’ and how he stands up for himself ultimately turning into a swan! ■ www.humancapitalonline.com t was the year 2000. Kiran was 32 then. Kiran was an electronics engineer by profession; Kiran had joined Procon India Limited‚ a respected name in electronics‚ both consumer and professional 10 years ago as a video
Premium Management Human resource management Performance management
Shailesh KD et al. / IJPPDR / 4(1)‚ 2014‚ 15-19. e-ISSN: 2249-7625 Print ISSN: 2249-7633 International Journal of Pharmacy Practice & Drug Research www.ijppdr.com REASONS FOR OUTSOURCING IN PHARMACEUTICAL INDUSTRY Shailesh Kumar Develpalli*¹‚ Malathi Jojula2‚ Bucha Reddy Ponakunti3 ¹Sr. Manager in General Administration Ricon Pharma Private Limited India‚ Hyderabad‚ Andhra Pradesh‚ India. ²Department of Pharmacy Microbiology‚ Sri Shivani College of Pharmacy‚ Warangal‚ Andhra Pradesh‚ India. ³Department
Premium Clinical trial Pharmaceutical industry Pharmacology
Glaxosmithkline is a global leader in the market of pharmaceutical goods and services‚ currently holding 7% of market share in this field. Formerly Glaxo Wellcome plc‚ the firm merged in December 2000 with Smithkline Beecham‚ a leading manufacturer of medical and consumer healthcare goods. ‚ however there is much dispute over the motives behind the merger and what Glaxo Wellcome sought to gain through the collaboration. This is of particular concern as following the merger‚ many shareholders and
Premium Pharmaceutical industry
TM Industries in 2012 A report from the Economist Intelligence Unit www.eiu.com/industry Industries in 2012 Foreword: Industries in 2012 W ith disappointing economic growth in the US and the prospect of outright collapse in the euro zone‚ it is hardly surprising that a majority of the 900 business executives we surveyed recently were pessimistic when we asked their outlook for the global economy in 2012. These survey results are discussed in detail in this report‚ along with our
Premium Automotive industry Emerging markets Financial services
Customer Education Antibiotic Classification Antibiotic Classification and Modes of Action Part # 60-00415-0 © bioMérieux‚ Inc.‚ Customer Education March 2008 1 Customer Education Antibiotic Classification bioMérieux‚ the blue logo and VITEK are used‚ pending and/or registered trademarks belonging to bioMérieux SA or one of its subsidiaries. CLSI is a registered trademark of Clinical Laboratory and Standards Institute‚ Inc. Zyvox is a registered trademark of Pfizer Caribe
Premium Bacteria Penicillin
Pharma in Europe: New Medicine for a New World Building Value-Based Healthcare Business Models As healthcare systems begin to pay for outcomes rather than products‚ smart patient-centric services will play a key role in the race to capture value. Building Value-Based Healthcare Business Models 1 The pharmaceutical and medical technology industries survived the recent financial crisis relatively unscathed‚ but they are being transformed nonetheless as healthcare systems switch their reimbursement
Premium Medicine Health care Health economics
GSK Marketing Planning | March 31 2013 | Calvin Cheung‚ Hussain Al Katib‚ Manpreet Budwal‚ Sandra Okechukwu | SOSTAC Review based on GlaxoSmithKline | Content Table of Contents 1.0 Introduction2 2.0 Situation Analysis3 2.1 PESTEL Analysis3 2.2 SWOT Analysis4 2.3 Boston Matrix5 2.4 Porter’s Five Forces Analysis6 3.0 Objectives8 4.0 Strategy9 4.1 Product9 4.2 Price9 4.3 Promotion9 4.4 Place10 4.5 Person10 4.6 Process10 4.7 Physical Evidence10 5.0 Tactics11 6.0 Action Plan12
Premium Marketing